We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ADC Synthesis in Flow

Video   May 18, 2016

 

About the Speaker
Graham B. Jones is Professor and Chair of Chemistry & Chemical Biology at Northeastern University in Boston, MA. He also serves as director of translational research for the Tufts Medical Center Clinical and Translational Science Institute. Jones was educated in the UK, receiving BSc (1986) and PhD (1989) degrees in chemistry from the University of Liverpool and the Imperial College of Science Technology and Medicine respectively. He then moved to Harvard University as a NATO fellow to work with E. J. Corey, the 1990 Nobelist. His research program is focused on the development of experimental therapeutics and has resulted in over 140 publications and generated in excess of $30M external funding. Examples include development of antibody-toxin conjugates, treatments for polyglutamine disorders, tissue activated image contrast agents, and cancer immunotherapies. He has been appointed to several editorial posts for scientific journals and is the recipient of numerous awards including the Leblanc Medal, the Leverhulme Prize, the CEM Technology Innovation Award and a DSc degree. Jones gave invited testimony at the 2010 congressional hearings on biopharmaceuticals, and serves as scientific advisor to a number of research foundations and corporations in the USA and UK.
AbstractThe use of continuous flow technology for the synthesis of protein bioconjugates will be presented. In addition to reagent proteins, monoclonal antibody conjugates will also be highlighted.

 
 
 
 

Recommended Videos

Operetta CLS High-Content Analysis System

Video

The Operetta CLS system is part of PerkinElmer's comprehensive HCS portfolio – from HCS systems and microplates to automation and informatics.

WATCH NOW

ULTImate YChemH: a powerful tool for drug target deconvolution

Video

What if I told you Hybrigenics Services can help you make the right decisions and optimize the success rate of your drug discovery and development programs?
Watch how with our animation video and discover our optimized ULTImate YChemH technology for drug target deconvolution.

WATCH NOW

Challenges & Solutions in Today's In Vitro Transporter Research Landscape

Video

Key concepts discussed in this webinar included: - Ramifications of recent FDA in vitro DDI guidance changes to transporter study designs - Challenges from diverse compounds in otherwise straightforward assays - Solutions to problems associated with specific compound characteristics - Case studies of problematic observations or data and the creative methods of troubleshooting applied

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE